Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETO2X-AMI: Oxygen Therapy in Suspected AMI
NCT01787110Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxygen in acute myocardial infarction (AMI) and unstable angina (2 arms), sponsored by Karolinska Institutet. Primary endpoint: All-cause mortality at one year at 1 year. Started Apr 2013; status: completed.
02
Drugs
oxygen
03
Conditions
acute myocardial infarction (AMI)unstable angina
Beyond the preview
Go deeper on NCT01787110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787110.